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Abstract
Purpose—The success of national immunization programs depends on the public’s confidence in 
vaccines. We sought to develop a scale for measuring confidence about adolescent vaccination in 
diverse populations of parents.
Methods—Data came from 9,623 parents who completed the 2010 National Immunization 
Survey-Teen, an annual, population-based telephone survey. Parents reported on a 13- to 17-year-
old child in their households. We used exploratory and confirmatory factor analysis to identify 
latent constructs underlying parents’ responses to 8 vaccination belief survey items (response scale 
0–10) conceptualized using the Health Belief Model. We assessed the scale’s psychometric 
properties overall and across demographic subgroups.
Results—Parents’ confidence about adolescent vaccination was generally high. Analyses 
provided support for three factors assessing benefits of vaccination (mean = 8.5), harms of 
vaccination (mean = 3.3), and trust in healthcare providers (mean = 9.0). The model showed good 
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fit both overall (comparative fit index = 0.97) and across demographic subgroups, although 
internal consistency was variable for the three factors. We found lower confidence among several 
potentially vulnerable subpopulations, including mothers with lower levels of education and 
parents whose children were of Hispanic ethnicity (both p<.05).
Conclusions—Our brief, three-factor scale offers an efficient way to measure confidence in 
adolescent vaccination across demographic subgroups. Given evidence of lower confidence by 
educational attainment and race/ethnicity, program planners should consider factors such as health 
literacy and cultural competence when designing interventions to promote adolescent vaccination 
to ensure these programs are fully accessible.
Keywords
adolescent health; vaccine hesitancy; meningococcal vaccine; human papillomavirus vaccine; 
tetanus vaccine; immunization
INTRODUCTION
Parents’ confidence in vaccines is critical to the success of national immunization programs. 
Unfortunately, in the case of adolescent vaccines, recent research suggests that many parents 
are not convinced that the benefits of vaccination outweigh the costs. For example, over 
30% of parents in the U.S. report having refused or delayed human papillomavirus (HPV) 
vaccine for their adolescent daughters; their reasons include doubts about safety, 
effectiveness, and whether the vaccine is needed [1]. Parents who have not gotten their 
children tetanus, diphtheria, and acellular pertussis (Tdap) or meningococcal vaccines also 
commonly report believing these vaccines are not necessary [2]. Increasing parents’ 
confidence in the value of adolescent vaccination is important for addressing parental refusal 
and delay, especially since adolescent vaccines have yet to attain the high coverage achieved 
for many early childhood vaccines [3].
Better measures of vaccination confidence could facilitate research and interventions aimed 
at addressing hesitancy toward adolescent vaccines. Although scales have been developed 
for specific vaccines [4] or for parents of younger children [5], the field currently lacks a 
composite measure capable of characterizing adolescent vaccination beliefs more 
holistically. Because research indicates that vaccine hesitancy varies by demographic 
characteristics [1,5–8], a scale that could perform reliably across diverse populations would 
be especially valuable.
To address this need, we developed the Vaccination Confidence Scale using data from a 
national, population-based sample of parents of adolescent children. To test the suitability of 
our scale for use in diverse populations, we assessed the scale’s properties by demographic 
factors including race/ethnicity, maternal educational attainment, and household income. 
Finally, we used the scale to assess subgroup differences in vaccination confidence.
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Participants and Data Source
We used existing data from the 2010 National Immunization Survey (NIS)–Teen, an annual, 
population-based survey sponsored by the Centers for Disease Control and Prevention [9]. 
Data collection included a telephone survey of respondents contacted through random digit 
dialing. Eligible respondents were parents or guardians who provided information about a 
randomly selected 13- to 17-year-old child in their household. For the sake of simplicity, we 
refer to these participants hereafter as “parents.”
The household response rate for the 2010 NIS-Teen, excluding the U.S. Virgin Islands, was 
58%, and resulted in an overall sample of 32,429 parents from all 50 states and select 
localities, including the District of Columbia. Data for this study came from a subset of 
11,754 parents who completed the “Parental Attitudes Module,” a special addendum 
administered in 2010 for two of the four quarters during which NIS-Teen data were 
collected. We excluded parents who did not provide responses to key variables (n=1,282), 
who took the survey in a language other than English (n=607), or who were dropped due to 
weighting procedures (n=242). Our final analytic sample consisted of 9,623 parents.
The National Center for Health Statistics (NCHS) Research Ethics Review Board approved 
data collection for NIS-Teen. Analysis of deidentified data from the survey is exempt from 
the federal regulations for the protection of human research participants. Analysis of 
restricted data through the NCHS Research Data Center was approved by the NCHS Ethics 
Review Board. The University of North Carolina Institutional Review Board ruled this study 
exempt from further review.
Measures
The Parental Attitudes Module assessed 11 beliefs about the vaccination of teenagers using 
an 11-point response scale that ranged from 0 (“strongly disagree”) to 10 (“strongly agree”). 
Items were conceptualized using the Health Belief Model, a theory of health behavior that 
researchers have successfully used to identify attitudes related to vaccination in early 
childhood and adolescence [7,10]. Topics included perceived benefits of vaccination such as 
disease prevention and perceived barriers to vaccination such as side effects (Figure 1). 
Given the extent to which prior research emphasizes the importance of trust in vaccination 
decisions [5,7,11–13], we included two items from the Parental Attitudes Module that 
assessed parents’ relationship with healthcare providers, including one general item that was 
not specific to vaccination. Because items in the Parental Attitudes Module are restricted 
variables that are not included in the 2010 NIS-Teen public-use dataset, we accessed these 
data through the NCHS Research Data Center.
The 2010 NIS-Teen also assessed demographic characteristics including the child’s age, sex, 
and race/ethnicity (Table 1). The survey assessed variables used to determine whether the 
child was eligible for the Vaccines for Children (VFC) Program, which provides free 
vaccines to populations with limited ability to pay, including uninsured and Medicaid-
eligible youth [14]. Respondents indicated their own relationship to the child as well as the 
age and educational attainment of the child’s mother. Household characteristics included 
Gilkey et al. Page 3













annual income and geographic location. We classified households as urban, suburban, or 
rural based on metropolitan statistical areas [15].
Statistical Analysis
We used factor analysis to identify the latent constructs underlying parents’ responses to the 
11 items on vaccination beliefs in the Parental Attitudes Module. First, we randomly 
selected a subset comprising half of the entire sample to conduct an exploratory factor 
analysis (EFA). We used principal factor extraction followed by oblique rotation, which 
allows correlation among the factors. We fit one-, two-, three-, and four-factor models, 
examining factor loadings for each model. We retained models for further analysis based on 
the following criteria: 1) number of factors with eigenvalues >1; 2) change in the curve of 
the scree plot; 3) signs of under-factoring (i.e., several items showing loadings >0.40 on 
more than one factor); 4) signs of over-factoring (i.e., several items showing loadings <0.30 
on all factors); and 5) likelihood ratio tests between models [16]. To create the most 
parsimonious scale possible, we examined each survey item individually and removed items 
from further analyses if they failed to load meaningfully on any factor (i.e., loading < .30).
Next, for each of the retained models, we performed a confirmatory factor analysis using the 
full sample. For multi-factor models, we matched subsets comprising 2–3 items each with 
the factors and fixed all other factor loadings to zero, resulting in a simple structure. To 
assess model fit, we used the root mean square error of approximation (RMSEA), which is a 
measure of how well the model is able to reproduce the observed correlations between the 
items on the scale, and the comparative fit index (CFI), which measures the degree to which 
the proposed model is superior to a model that assumes that all of the items on the scale are 
uncorrelated. We used guidelines of RMSEA ≤ 0.05 and CFI ≥ 0.95 to indicate highly 
acceptable, or “excellent” fit; we used RMSEA ≤ 0.06 and CFI ≥ 0.90 to indicate acceptable, 
or “good” fit [17,18]. For each model, we also conducted chi-squared goodness of fit tests 
for the entire sample and for each demographic subgroup. We compared the fits of candidate 
models using likelihood-ratio tests.
We used classical test theory methods to examine item performance for each candidate 
model. These methods, which included calculating coefficient alpha for each item as well as 
item-deleted alphas, help verify that each item contributes to the measurement of the latent 
constructs and that no single item detracts from overall scale reliability. We conducted these 
analyses using the full sample and for each demographic subgroup to verify that items 
performed similarly across variables prior research indicates may be associated with 
vaccination beliefs, refusal and delay. These variables included adolescent demographics 
(age, sex, race/ethnicity, VFC eligibility), mother’s educational attainment, household 
income, and MSA status [1,5–8].
For each model, we calculated mean factor scores (range: 0–10) by averaging the item 
responses within a particular factor. To assess how adolescent vaccination beliefs vary 
across populations, we also calculated mean factor scores for each demographic subgroup. 
For each grouping variable (e.g., sex, race/ethnicity, etc.), we used t-tests to assess whether 
sub-groups within that category differed from a reference group. We report raw frequencies 
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The mean age for children was 15.0 years, with similar numbers of males (51%) and females 
(49%) (Table 1). Most parents reported on children who were non-Hispanic white (66%), 
non-Hispanic black (16%), or Hispanic (11%). About one-third (34%) of teens had a mother 
with a high school degree or less education, and over one-tenth (14%) of teens lived in 
households with annual incomes below the poverty level.
Factor Analysis
Exploratory analysis—The results of the exploratory factor analysis yielded two 
candidate scales: a one-factor scale and a three-factor scale. The scales had 8 items, after 
dropping 3 items (“My teenager helps make the decision about whether he or she will 
receive a vaccine,” “I make a point to read and watch stories about health,” and 
“Vaccination should be delayed if a teenager has a minor illness”) because they did not 
meaningfully load onto any factor.
Confirmatory analysis of 1-factor scale—For the one-factor scale, we reverse-coded 
negative attitudes and labeled the resulting factor “General Confidence,” corresponding to 
positive parental attitudes toward adolescent vaccination (Figure 1, left side). Coefficient 
alpha for this general scale was 0.77 overall (Table 2), and in stratified analyses, values 
ranged from 0.70 to 0.80 across demographic subgroups (data not shown). The model 
showed marginally acceptable fit: χ2 (20) = 1367, p < 0.001; CFI = 0.93; RMSEA = 0.08. 
Standardized factor loadings ranged from 0.31 to 0.73 (all p < .05, Table 2).
Confirmatory analysis of 3-factor scale—The three-factor scale had factors with more 
specific interpretations (Figure 1, right side). The first factor, “Benefits,” consisted of four 
items related to the potential advantages and safety of vaccinating one’s teenager that was 
reliable for the overall sample and all subgroups we examined (overall α = 0.78; range 
across subgroups: 0.72–0.80). The second factor, “Harms,” comprised two items about 
perceived negatives related to adolescent vaccination, including possible side effects (overall 
α = 0.49; range: 0.45–0.54). The third factor, “Trust,” comprised two items relating to the 
parent and healthcare provider relationship (overall α = 0.51; range: 0.43–0.55).
The model for the three-factor scale showed good fit: χ2 (17) = 550; CFI = 0.97; RMSEA = 
0.06. For the entire sample and for all 22 sub-groups within the sample, likelihood-ratio tests 
indicated that the three-factor model exhibited better fit than the one-factor model, as shown 
by the large Δχ2 statistics (Table 3). Standardized factor loadings ranged from 0.41 to 0.84 
(all p < .05, Table 2) and were equal or larger in size than those achieved for the one-factor 
scale.
All factors in the three-factor scale correlated in the expected directions (Figure 1). Harms 
and Benefits were strongly negatively correlated (r=−0.73, SE=0.01). Benefits and Trust 
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were strongly positively correlated (r=0.69, SE=0.01). Harms and Trust were moderately 
negatively correlated (r=−0.49, SE=0.02).
Confidence among Demographic Subgroups
Overall confidence in adolescent vaccination was generally high (one-factor scale: M = 8.15, 
SE = 0.02) (Table 4). However, in stratified analyses of the one-factor scale, we found 
evidence of less favorable vaccination beliefs among several subpopulations: parents of 
adolescents of Hispanic versus non-Hispanic white ethnicity; parents of adolescents who 
were VFC versus non-VFC eligible; mothers with low or moderate versus high educational 
attainment; parents with moderate versus high household income; and parents in suburban or 
rural versus urban households. Mean differences by subgroup were generally small, ranging 
from 0.12 for mothers with high versus low educational attainment to 0.27 for white versus 
Hispanic adolescents.
The three-factor scale indicated that parents generally gave high ratings to Benefits and 
Trust (M = 8.45, SE = 0.03; M = 9.04, SE = 0.02, respectively) and low ratings to Harms (M 
= 3.34, SE = 0.04). In addition to the subgroup differences identified by the one-factor scale, 
the three-factor scale suggested less favorable vaccination beliefs among parents of 
adolescents who were female or from “other” racial/ethnic backgrounds. Differences in 
confidence were small to moderate, ranging from 0.12 on Trust for mothers with high versus 
low educational attainment to 0.43 on Harms for Hispanic versus non-Hispanic white 
adolescents.
DISCUSSION
Developed using data from a large, nationally-representative sample of parents, our 8-item 
Vaccination Confidence Scale offers an efficient measure of adolescent vaccination beliefs. 
Our scale fit the data best when divided into three factors assessing benefits of vaccination, 
harms of vaccination, and trust in healthcare providers. In terms of health behavior theory, 
the first two factors correspond as expected to two constructs central to the Health Belief 
Model (HBM): perceived benefits and barriers. Our third factor, Trust, may be interpreted as 
a modifying factor that is likely related to cues to action, a third HBM construct that 
describes triggers needed to prompt behavior. Parents with a high degree of trust in 
healthcare providers may be more likely to act on cues, such a provider’s recommendation, 
that are known to be highly predictive of adolescent vaccination [10,19–23]. By assessing 
the factors of Benefits, Harms, and Trust, the Vaccination Confidence Scale can inform 
interventions aimed at communicating benefits and addressing perceived barriers so as to 
increase parents’ interest in vaccination.
In addition to being brief, the Vaccination Confidence Scale offers consistency. In stratified 
analyses, the scale maintained good fit across demographic subgroups, suggesting that it can 
be used to assess vaccination confidence in diverse populations of parents. Such flexibility is 
important given that parental beliefs and behaviors, including vaccine refusal and delay, 
vary by characteristics such as race/ethnicity, maternal education, and household income 
[1,5–8].
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Using the scale, we found that parents’ confidence in vaccination was generally high, 
consistent with prior research [5,6,24–26]. However, we found evidence of lower levels of 
confidence in several subgroups of parents who may face special barriers to participating in 
immunization programs. Characteristics including racial/ethnic minority status, lower 
maternal education, and eligibility for the VFC program were associated with less favorable 
vaccination beliefs. Given these differences, interventions to improve vaccination 
confidence may require special attention to factors such as cultural competence and health 
literacy so as to ensure that programs are accessible to those who stand to benefit from them 
most.
Targeted interventions may also be valuable, and a further advantage of the three-factor 
scale is the ability to identify which clusters of beliefs drive subgroup differences in 
confidence. For example, the three-factor scale suggests that lower confidence among 
parents of Hispanic versus non-Hispanic white adolescents is due primarily to greater 
perceived harms of vaccination and lower trust in healthcare providers. By contrast, lower 
overall scale scores among suburban-and rural-versus urban-dwelling parents appear to be 
driven by lower perceived benefits of vaccination. Program planners can use these 
distinctions to develop targeted messages aimed at addressing parents’ concerns in an 
efficient manner.
Strengths of this study include the use of data from NIS-Teen, the largest and most rigorous 
national survey on adolescent immunization in the United States. Our nationally-
representative sample allowed for the development of a robust tool tested with respect to 
demographic characteristics known to correlate with vaccination beliefs. In addition, the 
Health Belief Model informed the development of scale items. This use of theory may offset 
the primary limitation of this study, which was the modest number of items available for 
scale development. Having a limited item pool is likely the reason for low coefficient alphas 
for the Harms and Trust factors. Only moderate correlation is to be expected of two-item 
factors, which can still have practical value in the context of good overall model fit [27–29]. 
Nevertheless, future iterations of the scale may benefit from further development of the 
Harms and Trust factors.
Future studies should also seek to assess the Vaccination Confidence Scale in other 
populations, including parents of younger adolescents. Although we did not find evidence to 
suggest that vaccination confidence varied by child’s age, our sample consisted of parents of 
13-to 17-year-olds who were past the age for routine administration of adolescent vaccines. 
To the extent that parents’ beliefs were informed by past experience with adolescent 
vaccination, our respondents’ scale scores may differ from those of parents with younger 
children not yet eligible for adolescent vaccines. Future research should also assess our 
scale’s ability to predict parental refusal and delay of adolescent vaccines. If successfully 
validated, our brief measure may hold promise as a clinical screening tool that primary care 
providers can use to efficiently evaluate the nature and extent of parents’ concerns about 
adolescent vaccination.
In conclusion, our brief, three-factor Vaccination Confidence Scale offers an efficient way 
to assess vaccination beliefs among parents of adolescent children. This study lends support 
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for using our scale in diverse populations of parents, and variation we found in vaccination 
confidence by demographic factors speaks to the importance of using measures that exhibit 
desirable statistical properties across different groups. For adolescent vaccines, attaining the 
widespread coverage achieved for early childhood vaccines will require a concerted effort to 
address barriers to vaccination, including parental beliefs. Perceived benefits, harms, and 
trust offer three opportunities for better meeting parents’ informational and relational needs 
so that adolescent vaccination is a decision they can make with confidence.
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• We developed a brief, three-factor scale for measuring confidence about 
adolescent vaccination.
• The scale showed good fit both overall (CFI=0.97) and across demographic 
subgroups.
• Using the scale to assess a national sample of parents, we found that confidence 
was generally high.
• However, we found lower confidence among subgroups with lower education or 
of Hispanic ethnicity.
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Table 1




  13 1,887 19.85
  14 1,918 19.71
  15 1,957 19.77
  16 2,014 21.49
  17 1,847 19.18
 Sex
  Male 5,003 50.97
  Female 4,620 49.03
 Race/ethnicity
  Non-Hispanic white 6,892 65.93
  Non-Hispanic black 1,116 15.94
  Hispanic 837 11.18
  Other 778 6.96
 Vaccines for Children eligibility
  Yes 2,000 23.52
  No 5,636 55.13
  Not reported 1,987 21.35
Parent characteristics
 Relationship to child
  Mother/female guardian 7,561 77.55
  Father/male guardian 1,605 16.66
  Grandparent or other 457 5.79
 Mother’s age
  ≤ 34 years 653 7.27
  35–44 years 3,876 43.22
  ≥ 45 years 5,094 49.51
 Mother’s education
  12 years or less 2,552 34.44
  Some college, no degree 2,909 26.89
  College degree or more 4,162 38.68
Household characteristics
 Region
  Northeast 1,895 18.54
  Midwest 2,080 22.91
  South 3,562 37.76
  West 2,086 20.78
 Annual incomea
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N (%)
  Below poverty 1,093 14.39
  Above poverty, ≤$75,000 3,884 39.59
  >$75,000 4,272 42.17
  Not reported 374 3.86
 MSA status
  Urban 3,674 34.31
  Suburban 3,672 47.85
  Rural 2,277 17.84
Note. We report raw frequencies and weighted percentages. Percentages may not total 100 due to rounding.
a
Poverty level based on 2009 U.S. Census poverty thresholds
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Table 3
χ2 tests of fit for nested models.
1-Factor Model χ2 3-Factor Model χ2 Δχ2 Model to Retain
Entire sample 1368 550 817 3 Factors
Child characteristics
 Age
  13 226 120 106 3 Factors
  14 277 121 156 3 Factors
  15 260 110 150 3 Factors
  16 351 173 178 3 Factors
  17 286 131 155 3 Factors
 Sex
  Males 692 296 397 3 Factors
  Females 686 265 421 3 Factors
 Race/ethnicity
  Non-Hispanic white 920 416 504 3 Factors
  Non-Hispanic black 208 50 157 3 Factors
  Hispanic 141 75 67 3 Factors
  Other 156 66 90 3 Factors
 Vaccines for Children eligibility
  Yes 357 113 244 3 Factors
  No 724 348 376 3 Factors
Parent characteristics
 Mother’s education
  12 years or less 489 131 358 3 Factors
  Some college, no degree 393 188 205 3 Factors
  College degree or more 540 300 240 3 Factors
Household characteristics
 Annual income
  Below poverty 179 58 121 3 Factors
  Above poverty, ≤$75,000 617 232 386 3 Factors
  >$75,000 569 282 289 3 Factors
 MSA status
  Urban 565 209 357 3 Factors
  Suburban 503 240 263 3 Factors
  Rural 340 163 176 3 Factors
Note: The change in χ2 is statistically significant at the 0.001-level for 3 degrees of freedom if it exceeds 16.3.
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Full sample 8.15 (0.02) 8.45 (0.03) 3.34 (0.04) 9.04 (0.02)
Sex
 Males (reference) 8.16 (0.04) 8.44 (0.04) 3.26 (0.06) 9.02 (0.03)
 Females 8.14 (0.03) 8.47 (0.04) 3.44 (0.06)* 9.06 (0.04)
Race/ethnicity
 Non-Hispanic white (reference) 8.18 (0.03) 8.45 (0.03) 3.28 (0.04) 9.12 (0.02)
 Non-Hispanic black 8.21 (0.08) 8.55 (0.09) 3.33 (0.13) 9.05 (0.08)
 Hispanic 7.91 (0.10)* 8.31 (0.13) 3.71 (0.15)* 8.73 (0.11)*
 Other 8.07 (0.09) 8.44 (0.08) 3.40 (0.17) 8.81 (0.10)*
Vaccines for Children eligibility
 Yes 8.11 (0.06)* 8.47 (0.08) 3.52 (0.10)* 9.02 (0.06)*
 No (reference) 8.28 (0.03) 8.55 (0.03) 3.15 (0.05) 9.18 (0.03)
Mother’s education
 12 years or less 8.12 (0.04)* 8.48 (0.05) 3.51 (0.08)* 9.01 (0.04)*
 Some college, no degree 8.07 (0.05)* 8.36 (0.06) 3.40 (0.08)* 8.95 (0.06)*
 College degree or more (reference) 8.24 (0.04) 8.49 (0.04) 3.16 (0.06) 9.13 (0.03)
Annual income
 Below poverty 8.23 (0.08)* 8.66 (0.09)* 3.44 (0.15) 9.03 (0.08)
 Above poverty, ≤$75,000 (reference) 8.05 (0.04) 8.36 (0.04) 3.47 (0.06) 8.96 (0.04)
 >$75,000 8.23 (0.04)* 8.48 (0.05) 3.16 (0.06)* 9.13 (0.04)*
MSA status
 Urban (reference) 8.24 (0.04) 8.59 (0.05) 3.30 (0.07) 9.10 (0.04)
 Suburban 8.12 (0.04)* 8.42 (0.04)* 3.33 (0.06) 8.99 (0.04)
 Rural 8.04 (0.05)* 8.28 (0.06)* 3.46 (0.09) 9.06 (0.05)
Note. Mean factor scores were not statistically different by child’s age. SE: standard error.
*
Statistically significant difference from reference group mean.
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